195 related articles for article (PubMed ID: 36155102)
21. The use of convalescent plasma therapy in the management of a pregnant woman with COVID-19: a case report.
Moura LW; Liao AW; Negrini R; Zlotnik E
Einstein (Sao Paulo); 2022; 20():eRC6550. PubMed ID: 35195192
[TBL] [Abstract][Full Text] [Related]
22. Convalescent Plasma the Experience and Journey from Blockbuster to Incognito: A Single Centre Experience.
Negi G; Kaur D; Jain A; Mohan YK; Meinia SK; Kaur P; Panda PK; Kalita D; Ravikant
Recent Adv Antiinfect Drug Discov; 2023; 18(3):188-196. PubMed ID: 35733306
[TBL] [Abstract][Full Text] [Related]
23. An evaluation of the results of convalescent plasma therapy applied to pregnant women diagnosed as COVID-19- positive in a pandemic center: A prospective cohort study.
Erol SA; Tanaçan A; Apaydın H; Ayhan ŞG; Oluklu D; Hendem DU; Ünlü S; Erden A; Tekin ÖM; Omma A; Ateş İ; Küçükşahin O; Şahin D
Turk J Med Sci; 2022 Jun; 52(3):554-564. PubMed ID: 36326345
[TBL] [Abstract][Full Text] [Related]
24. "Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial".
Teofili L; Landolfi R; Cingolani A; Antinori A; Vecchiet J; Sanguinetti M; Gasbarrini A; Pasciuto T; Orlando N; Lamonica S
Trials; 2020 Oct; 21(1):875. PubMed ID: 33092632
[TBL] [Abstract][Full Text] [Related]
25. Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma.
Park H; Tarpey T; Liu M; Goldfeld K; Wu Y; Wu D; Li Y; Zhang J; Ganguly D; Ray Y; Paul SR; Bhattacharya P; Belov A; Huang Y; Villa C; Forshee R; Verdun NC; Yoon HA; Agarwal A; Simonovich VA; Scibona P; Burgos Pratx L; Belloso W; Avendaño-Solá C; Bar KJ; Duarte RF; Hsue PY; Luetkemeyer AF; Meyfroidt G; Nicola AM; Mukherjee A; Ortigoza MB; Pirofski LA; Rijnders BJA; Troxel A; Antman EM; Petkova E
JAMA Netw Open; 2022 Jan; 5(1):e2147375. PubMed ID: 35076698
[TBL] [Abstract][Full Text] [Related]
26. Early safety indicators of COVID-19 convalescent plasma in 5000 patients.
Joyner MJ; Wright RS; Fairweather D; Senefeld JW; Bruno KA; Klassen SA; Carter RE; Klompas AM; Wiggins CC; Shepherd JR; Rea RF; Whelan ER; Clayburn AJ; Spiegel MR; Johnson PW; Lesser ER; Baker SE; Larson KF; Ripoll JG; Andersen KJ; Hodge DO; Kunze KL; Buras MR; Vogt MN; Herasevich V; Dennis JJ; Regimbal RJ; Bauer PR; Blair JE; Van Buskirk CM; Winters JL; Stubbs JR; Paneth NS; Verdun NC; Marks P; Casadevall A
J Clin Invest; 2020 Sep; 130(9):4791-4797. PubMed ID: 32525844
[TBL] [Abstract][Full Text] [Related]
27. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
28. SARS-CoV-2 Infection Among Hospitalized Pregnant Women: Reasons for Admission and Pregnancy Characteristics - Eight U.S. Health Care Centers, March 1-May 30, 2020.
Panagiotakopoulos L; Myers TR; Gee J; Lipkind HS; Kharbanda EO; Ryan DS; Williams JTB; Naleway AL; Klein NP; Hambidge SJ; Jacobsen SJ; Glanz JM; Jackson LA; Shimabukuro TT; Weintraub ES
MMWR Morb Mortal Wkly Rep; 2020 Sep; 69(38):1355-1359. PubMed ID: 32970660
[TBL] [Abstract][Full Text] [Related]
29. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
[TBL] [Abstract][Full Text] [Related]
30. ADRS due to COVID-19 in midterm pregnancy: successful management with plasma transfusion and corticosteroids.
Soleimani Z; Soleimani A
J Matern Fetal Neonatal Med; 2022 Aug; 35(16):3040-3043. PubMed ID: 32715804
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of convalescent plasma for treatment of COVID-19 in Uganda.
Kirenga B; Byakika-Kibwika P; Muttamba W; Kayongo A; Loryndah NO; Mugenyi L; Kiwanuka N; Lusiba J; Atukunda A; Mugume R; Ssali F; Ddungu H; Katagira W; Sekibira R; Kityo C; Kyeyune D; Acana S; Aanyu-Tukamuhebwa H; Kabweru W; Nakwagala F; Bagaya BS; Kimuli I; Nantanda R; Buregyeya E; Byarugaba B; Olaro C; Mwebesa H; Joloba ML; Siddharthan T; Bazeyo W
BMJ Open Respir Res; 2021 Aug; 8(1):. PubMed ID: 34376401
[TBL] [Abstract][Full Text] [Related]
32. Multi-institutional experience with COVID-19 convalescent plasma in children.
Jacquot C; Gordon O; Noland D; Donowitz JR; Levy E; Jain S; Willis Z; Rimland C; Loi M; Arrieta A; Annen K; Drapeau N; Osborne S; Ardura MI; Arora S; Zivick E; Delaney M
Transfusion; 2023 May; 63(5):918-924. PubMed ID: 36965173
[TBL] [Abstract][Full Text] [Related]
33. Pregnancy and Perinatal Outcomes of Women With Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Analysis.
Liu D; Li L; Wu X; Zheng D; Wang J; Yang L; Zheng C
AJR Am J Roentgenol; 2020 Jul; 215(1):127-132. PubMed ID: 32186894
[No Abstract] [Full Text] [Related]
34. Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study.
Abolghasemi H; Eshghi P; Cheraghali AM; Imani Fooladi AA; Bolouki Moghaddam F; Imanizadeh S; Moeini Maleki M; Ranjkesh M; Rezapour M; Bahramifar A; Einollahi B; Hosseini MJ; Jafari NJ; Nikpouraghdam M; Sadri N; Tazik M; Sali S; Okati S; Askari E; Tabarsi P; Aslani J; Sharifipour E; Jarahzadeh MH; Khodakarim N; Salesi M; Jafari R; Shahverdi S
Transfus Apher Sci; 2020 Oct; 59(5):102875. PubMed ID: 32694043
[TBL] [Abstract][Full Text] [Related]
35. COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: A multicenter interventional study.
Alsharidah S; Ayed M; Ameen RM; Alhuraish F; Rouheldeen NA; Alshammari FR; Embaireeg A; Almelahi M; Adel M; Dawoud ME; Aljasmi MA; Alshammari N; Alsaeedi A; Al-Adsani W; Arian H; Awad H; Alenezi HA; Alzafiri A; Gouda EF; Almehanna M; Alqahtani S; Alshammari A; Askar MZ
Int J Infect Dis; 2021 Feb; 103():439-446. PubMed ID: 33285283
[TBL] [Abstract][Full Text] [Related]
36. Multi-center matched cohort study of convalescent plasma for hospitalized patients with COVID-19.
Zhou CK; Bennett MM; Villa CH; Hammonds KP; Lu Y; Ettlinger J; Priest EL; Gottlieb RL; Davis S; Mays E; Clarke TC; Shoaibi A; Wong HL; Anderson SA; Kelly RJ
PLoS One; 2022; 17(8):e0273223. PubMed ID: 35980913
[TBL] [Abstract][Full Text] [Related]
37. A Multicenter, Prospective, Observational, Cohort-Controlled Study of Clinical Outcomes Following Coronavirus Disease 2019 (COVID-19) Convalescent Plasma Therapy in Hospitalized Patients With COVID-19.
Chauhan L; Pattee J; Ford J; Thomas C; Lesteberg K; Richards E; Bernas CA; Loi M; Dumont L; Annen K; Berg M; Zirbes M; Knight V; Miller A; Jenkins TC; Bennett TD; Monkowski D; Boxer RS; Beckham JD
Clin Infect Dis; 2022 Aug; 75(1):e466-e472. PubMed ID: 34549274
[TBL] [Abstract][Full Text] [Related]
38. Should timing be considered before abandoning convalescent plasma in covid-19? Results from the Turkish experience.
Ateş İ; Erden A; Güven SC; Gürler EK; Çağlayan A; Güçbey Ö; Apaydın H; Şahiner ES; Küçük H; Varan Ö; Omma A; Küçükşahin O
Transfus Apher Sci; 2021 Dec; 60(6):103238. PubMed ID: 34412949
[TBL] [Abstract][Full Text] [Related]
39. Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19.
Körper S; Weiss M; Zickler D; Wiesmann T; Zacharowski K; Corman VM; Grüner B; Ernst L; Spieth P; Lepper PM; Bentz M; Zinn S; Paul G; Kalbhenn J; Dollinger MM; Rosenberger P; Kirschning T; Thiele T; Appl T; Mayer B; Schmidt M; Drosten C; Wulf H; Kruse JM; Jungwirth B; Seifried E; Schrezenmeier H;
J Clin Invest; 2021 Oct; 131(20):. PubMed ID: 34464358
[TBL] [Abstract][Full Text] [Related]
40. Convalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases.
Ljungquist O; Lundgren M; Iliachenko E; Månsson F; Böttiger B; Landin-Olsson M; Wikén C; Rosendal E; Överby AK; Wigren BJ; Forsell MNE; Kjeldsen-Kragh J; Rasmussen M; Kahn F; Holm K
Infect Dis (Lond); 2022 Apr; 54(4):283-291. PubMed ID: 34878955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
